Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Disease × tivozanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 2 Neoplasm Metastasis 1 Disease 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

tivozanib 1 Triamcinolone Acetonide 1 Quality of Life 1 Mechlorethamine 1 Erlotinib Hydrochloride 1 Counseling 1 Biopsy 1 Bexarotene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01728181 2013-07-25

A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation

University of Utah

Phase 1/2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡